Blood product required for the treatment of TTP patients
University Hospitals of Leicester NHS TrcontractContracts Finder ↗Ref CF-1009100D0O000000rwimUAA1complete
Estimated value
£98k
Awarded value
£98k
Awarded 01 Aug 2022
Suppliers
1
Lots
1
1 awarded
Published
03 Aug 2022
Deadline 01 Jun 2022
Description
Octaplas, blood product required for the treatment of TTP patients. CMU National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B Offer reference number: CM/PHS/19/5576
Scope
- Reference
- CF-1009100D0O000000rwimUAA1
- Total value
- £97,500 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 30 Jun 2022 to 29 Jun 2024
- CPV classifications
- 33141510
Submission & procedure
- Submission deadline
- 01 Jun 2022, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£98k
Award date
01 Aug 2022
Contract start
30 Jun 2022
Contract end
29 Jun 2024
Awarded to
Awarded suppliers· 1 supplier
Awarded 01 Aug 2022 · Contract period 30 Jun 2022 — 29 Jun 2024
Award value
£98k
Other contracts from University Hospitals of Leicester NHS Tr
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Octapharma Limited· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Octapharma - Blood Disorder Treatment products (inc Haemophilia A & B) | contract | £72k | 12 Mar 2025 |
| NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin | contract | — | 20 Jan 2025 |
| Human Derived Blood Products | contract | — | 28 Aug 2024 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 | contract | — | 11 Jun 2024 |
| Octapharma Ltd - Octaplas LG | contract | £53k | 14 Jun 2023 |
| Octaplex Treatment | contract | £100k | 10 May 2023 |
| NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B | contract | — | 04 Jul 2022 |
| Human Normal Immunoglobulin and Anti-D Immunoglobulin | contract | £64.3m | 23 Jul 2021 |
| NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin | contract | — | 22 Jul 2021 |
| NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga) | contract | — | 11 Jun 2021 |